Nexaph peptides represent a promising clinical strategy targeting illness progression. These modified entities leverage the unique properties of short peptide sequences to affect cellular processes involved in reaction, fibrosis, and tumor proliferation. Research demonstrate their possibility for addressing a variety of chronic diseases, offering a